Complex relationships of socioeconomic status with vascular and Alzheimer’s pathways on cognition

Introduction: AD and CVD, which frequently co-occur, are leading causes of age-related cognitive decline. We assessed how demographic factors, socioeconomic status (SES) as indicated by education and occupation, vascular risk factors, and a range of biomarkers associated with both CVD (including whi...

Full description

Bibliographic Details
Published in:	NeuroImage: Clinical
Main Authors:	Dror Shir, Jonathan Graff-Radford, Angela J. Fought, Timothy G. Lesnick, Scott A. Przybelski, Maria Vassilaki, Val J. Lowe, David S. Knopman, Mary M. Machulda, Ronald C. Petersen, Clifford R. Jack, Jr, Michelle M. Mielke, Prashanthi Vemuri
Format:	Article
Language:	English
Published:	Elsevier 2024-01-01
Subjects:	PET imaging Amyloid Tau Cognition Vascular health
Online Access:	http://www.sciencedirect.com/science/article/pii/S2213158224000731

Similar Items

Performance of the Lumipulse plasma Aβ42/40 and pTau181 immunoassays in the detection of amyloid pathology
by: Daniel J. Figdore, et al.
Published: (2024-01-01)

Relationship between tau-PET and quantitative susceptibility mapping in atypical Alzheimer’s disease
by: Neha Singh-Reilly, et al.
Published: (2025-07-01)

Evaluation and interpretation of DTI-ALPS, a proposed surrogate marker for glymphatic clearance, in a large population-based sample
by: Siddhartha Satpathi, et al.
Published: (2025-08-01)

Subtle cognitive impairment as a marker of Alzheimer's pathologies and clinical progression in cognitively normal individuals
by: Xue‐Ning Shen, et al.
Published: (2021-01-01)

The relationships between neuroinflammation, beta-amyloid and tau deposition in Alzheimer’s disease: a longitudinal PET study
by: Rola Ismail, et al.
Published: (2020-05-01)

Implication of tau propagation on neurodegeneration in Alzheimer’s disease
by: Daniel Lamontagne-Kam, et al.
Published: (2023-07-01)

Relationship of amyloid beta and neurofibrillary tau deposition in Neurodegeneration in Aging Down Syndrome (NiAD) study at baseline
by: DL Tudorascu, et al.
Published: (2020-01-01)

Clinically meaningful changes in cognitive and functional outcomes in a population‐based study of cognitive aging
by: Jeremiah A. Aakre, et al.
Published: (2025-07-01)

NODDI in gray matter is a sensitive marker of aging and early AD changes
by: Xi Yu, et al.
Published: (2024-07-01)

Identifying longitudinal cognitive resilience from cross-sectional amyloid, tau, and neurodegeneration
by: Rory Boyle, et al.
Published: (2024-07-01)

Association of the digital clock drawing test with amyloid and tau PET biomarkers in low age risk adults
by: Huitong Ding, et al.
Published: (2025-04-01)

Visual reading for [18F]Florzolotau ([18F]APN-1607) tau PET imaging in clinical assessment of Alzheimer’s disease
by: Huan-Chun Lin, et al.
Published: (2023-05-01)

Illuminating Tau Aggregates: Multiscale Approaches for Detection, Imaging, and Understanding
by: Kaustubh R. Bhuskute, et al.
Published: (2025-10-01)

Multimodal comparisons of QSM and PET in neurodegeneration and aging
by: Petrice M. Cogswell, et al.
Published: (2023-06-01)

Artificial Intelligence in PET Imaging for Alzheimer’s Disease: A Narrative Review
by: Andrea Marongiu, et al.
Published: (2025-09-01)

Rock inhibitors in Alzheimer’s disease
by: Chao Zheng, et al.
Published: (2025-03-01)

Can white matter hyperintensities based Fazekas visual assessment scales inform about Alzheimer’s disease pathology in the population?
by: Aishwarya Pradeep, et al.
Published: (2024-07-01)

Soluble P‐tau217 reflects amyloid and tau pathology and mediates the association of amyloid with tau
by: Niklas Mattsson‐Carlgren, et al.
Published: (2021-05-01)

Characterization of Alzheimer’s tau biomarker discordance using plasma, CSF, and PET
by: Yu Guo, et al.
Published: (2021-05-01)

Direct comparison between 18F-Flortaucipir tau PET and quantitative susceptibility mapping in progressive supranuclear palsy
by: Ryota Satoh, et al.
Published: (2024-02-01)

Assessment of Alzheimer’s disease-related biomarkers in patients with obstructive sleep apnea: A systematic review and meta-analysis
by: Wenqi Cui, et al.
Published: (2022-10-01)

Amyloid beta–independent sleep markers associated with early regional tau burden and cortical thinning
by: Laura Stankeviciute, et al.
Published: (2024-07-01)

Mitochondrial complex I abnormalities is associated with tau and clinical symptoms in mild Alzheimer’s disease
by: Tatsuhiro Terada, et al.
Published: (2021-04-01)

Understanding recent advances in non‐amyloid/non‐tau (NANT) biomarkers and therapeutic targets in Alzheimer's disease
by: Linda J. Van Eldik, et al.
Published: (2024-10-01)

Medial temporal lobe atrophy patterns in early-versus late-onset amnestic Alzheimer’s disease
by: Anika Wuestefeld, et al.
Published: (2024-09-01)

Neuropathology, Neuroimaging, and Fluid Biomarkers in Alzheimer’s Disease
by: Helena Colvee-Martin, et al.
Published: (2024-03-01)

Assessment of Alzheimer's Disease Imaging Biomarkers in World Trade Center Responders with Cognitive Impairment at Midlife
by: Minos Kritikos, et al.
Published: (2022-12-01)

Assessing network degeneration and phenotypic heterogeneity in genetic frontotemporal lobar degeneration by decoding FDG-PET
by: Nick Corriveau-Lecavalier, et al.
Published: (2024-01-01)

Dual‐Phase C‐11 PiB PET Images for Detecting Tau Pathology in Cerebral Amyloid Angiopathy
by: Meng‐Ting Chiang, et al.
Published: (2025-05-01)

Alzheimer’s Disease: Models and Molecular Mechanisms Informing Disease and Treatments
by: Kaden L. Nystuen, et al.
Published: (2024-01-01)

Curcumin as Scaffold for Drug Discovery against Neurodegenerative Diseases
by: Filippa Lo Cascio, et al.
Published: (2021-02-01)

Inert and seed-competent tau monomers suggest structural origins of aggregation
by: Hilda Mirbaha, et al.
Published: (2018-07-01)

Tau Protein and β-Amyloid Associated with Neurodegeneration in Myelin Oligodendrocyte Glycoprotein-Induced Experimental Autoimmune Encephalomyelitis (EAE), a Mouse Model of Multiple Sclerosis
by: Grażyna Pyka-Fościak, et al.
Published: (2024-12-01)

Neuroimaging assessment of early and late neurobiological sequelae of traumatic brain injury: implications for CTE
by: Mark eSundman, et al.
Published: (2015-09-01)

Quantitative proteomics of cerebrospinal fluid from African Americans and Caucasians reveals shared and divergent changes in Alzheimer’s disease
by: Erica S. Modeste, et al.
Published: (2023-07-01)

The neutrophil to lymphocyte ratio associates with markers of Alzheimer’s disease pathology in cognitively unimpaired elderly people
by: Tovia Jacobs, et al.
Published: (2024-05-01)

Diagnostic Accuracy of the Five-Word Test for Mild Cognitive Impairment Due to Alzheimer’s Disease
by: Chiara Fornari, et al.
Published: (2022-04-01)

Photo-Oxygenation as a New Therapeutic Strategy for Neurodegenerative Proteinopathies by Enhancing the Clearance of Amyloid Proteins
by: Ikumi Tomizawa, et al.
Published: (2022-06-01)

Comparison of plasma p-tau217 and p-tau181 in predicting amyloid positivity and prognosis among Korean memory clinic patients
by: Hyuk Sung Kwon, et al.
Published: (2025-03-01)

Interplay Between Aging and Tau Pathology in Alzheimer’s Disease: Mechanisms and Translational Perspectives
by: Mohammed Alrouji, et al.
Published: (2025-06-01)